MCM7 knockdown significantly inhibited cell proliferation via suppressing cyclin D1 expression in HCC cell lines, suggesting that MCM7 might be a potential therapeutic target for HCC. This evidence concerns the gene MCM7 and hepatocellular carcinoma.